The Uttarakhand authority has cancelled the licenses for 14 Patanjali products

According to the affidavit, the Uttarakhand government’s State Licencing Authority issued a public notice informing that publication of advertisements in violation of the law will result in serious disciplinary and legal action, including a fine or imprisonment

New Delhi: In an affidavit, the Uttarakhand government informed the Supreme Court that it has granted permission to file a complaint against Baba Ramdev’s Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the drug advertising law and has suspended manufacturing licenses for 14 of their products.
According to the affidavit, the Uttarakhand government’s State Licencing Authority issued a public notice informing that publication of advertisements in violation of the law will result in serious disciplinary and legal action, including a fine or imprisonment.

According to the affidavit filed by the State Licensing Authority, Ayurvedic and Unani Services, on April 12, the Drug Inspector, Haridwar was granted permission to file a complaint against Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The manufacturing licenses for 14 of their products—”Swasari Gold,” “Swasari Vati, Bronchom,” “Swasari Pravahi,” “Swasari Avaleh,” “MuktaVati Extra Power,” “Lipidom,” “Bp Grit,” “Madhugrit,” “MadhunashiniVati Extra Power,” “Livamrit Advance,” “Livogrit,” “Eyegrit Gold,” and “Patanjali Drishti Eye Drop,” were suspended with immediate effect, according to an order dated April 15, 2024, from the SLA to Divya Pharmacy and Respondent No. 5-Patanjali Ayurved Ltd.

“The District Ayurvedic and Unani Officer, Haridwar filed a criminal complaint before the Chief Judicial Magistrate, Haridwar against Swami Ramdev, Acharya Balkrishna, Divya Pharmacy and Patanjali Ayurved Limited under Sections 3, 4 and 7 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954,” according to the affidavit.

The SLA declared that it will keep taking all necessary actions against Patanjali Ayurved Ltd. and Divya Pharmacy in accordance with the legal process and the rulings made by the Supreme Court.

Read also:-

Sarvadanand Barnwal Appointed as Director in the Department of Land Resources

The State Licencing Authority’s then-Joint Director and all other officers occupying the position of District Ayurvedic and Unani Officer, Haridwar, from 2018 to the present, were directed by the top court to file their separate affidavits justifying their inactivity, in an order dated April 10.

The Drugs and Magic Remedies (Objectionable Advertisements) Act forbids the promotion of specific products for the treatment of specific diseases and disorders, such as diabetes, heart disease, high or low blood pressure, and obesity. The Indian Medical Association has filed a lawsuit against Patanjali for violating this law.

The ayurvedic company had previously made an undertaking before the Supreme Court that it would not make any casual statements claiming the medicinal efficacy of its products, nor would it advertise or brand them in violation of the law, and would not make any statement against any system of medicine to the media in any form.